Currently pregnant

Patients who are surgical or ablation candidates as determined by multidisciplinary hepatobiliary tumor conference.

Arterial anatomy which would preclude selective transarterial chemoembolization

Patients who have a INR or platelet count which are not correctable to \<1.8 and \>35,000 respectively

Patients with extrahepatic metastases

Patients with portal vein invasion

Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin